Myovant Sciences announces pricing of $75.0 million public offering of common shares
Myovant Sciences announced pricing of its underwritten public offering of 3,333,334 of its common shares at a price to the public of $22.50 per share. Gross proceeds are expected to be $75.0 million. Myovant granted underwriters a 30-day option to purchase up to an additional 500,000 of its shares. July 12, 2018